cd 437 and fenretinide
cd 437 has been researched along with fenretinide in 12 studies
Compound Research Comparison
| Studies (cd 437) | Trials (cd 437) | Recent Studies (post-2010) (cd 437) | Studies (fenretinide) | Trials (fenretinide) | Recent Studies (post-2010) (fenretinide) |
|---|---|---|---|---|---|
| 134 | 0 | 26 | 881 | 93 | 215 |
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Adamo, S; Avvisati, G; Benedetti, L; Diverio, D; Gambacorti-Passerini, C; Grignani, F; Jetten, AM; Levin, AA; Lo Coco, F; Nervi, C; Pelicci, PG; Scicchitano, BM | 1 |
| Pfahl, M; Piedrafita, FJ | 1 |
| Holmes, WF; Soprano, DR; Soprano, KJ; Wu, S; Zhang, D | 1 |
| Bernassola, F; Lovat, PE; Malcolm, AJ; Melino, G; Pearson, AD; Piacentini, M; Ranalli, M; Redfern, CP; Tilby, M | 2 |
| Fontana, JA; Rishi, AK | 1 |
| Holmes, WF; Soprano, DR; Soprano, KJ | 3 |
| Kim, HJ; Lotan, R | 1 |
| Ding, H; Feugang, JM; Grossman, HB; Liebert, M; Liu, J; Qian, L; Wang, X; Wu, S; Zhou, J; Zou, C | 1 |
Reviews
3 review(s) available for cd 437 and fenretinide
| Article | Year |
|---|---|
Retinoids and ovarian cancer.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Female; Fenretinide; Humans; Ovarian Neoplasms; Retinoids | 2000 |
Classical and novel retinoids: their targets in cancer therapy.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Fenretinide; Humans; Neoplasms; Receptors, Retinoic Acid; Retinoids | 2002 |
Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Female; Fenretinide; Genes, p53; Humans; Mitochondria; Mutation; Ovarian Neoplasms; Retinoids | 2004 |
Other Studies
9 other study(ies) available for cd 437 and fenretinide
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Topics: Apoptosis; Benzoates; CD18 Antigens; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytosol; Drug Resistance, Neoplasm; Enzyme Induction; Fenretinide; Gene Expression Regulation, Leukemic; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Protein Multimerization; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transglutaminases; Translocation, Genetic; Tretinoin; Tumor Cells, Cultured | 1996 |
Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation.
Topics: Apoptosis; Caspase 1; Caspase 2; Caspases; Cysteine Endopeptidases; Cytosol; Fenretinide; Gene Expression Regulation, Neoplastic; Humans; Protein Binding; Proteins; Retinoids; Sp1 Transcription Factor; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Fenretinide; Flow Cytometry; Free Radicals; Humans; Neuroblastoma; Retinoids; Time Factors; Tretinoin; Tumor Cells, Cultured | 2000 |
Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents.
Topics: Antineoplastic Agents; Apoptosis; Child; Drug Synergism; Fenretinide; Free Radicals; Humans; Neuroblastoma; Retinoids; Tumor Cells, Cultured | 2000 |
Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Division; Cytochrome c Group; Drug Resistance, Neoplasm; Enzyme Activation; Female; Fenretinide; Humans; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinases; Nuclear Receptor Subfamily 4, Group A, Member 1; Ovarian Neoplasms; Oxygen; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Receptors, Steroid; Receptors, Thyroid Hormone; Retinoids; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
Topics: Apoptosis; Caspases; Cell Division; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Female; Fenretinide; Humans; Intracellular Membranes; Microscopy, Confocal; Mitochondria; Ovarian Neoplasms; Retinoids; Tumor Cells, Cultured | 2003 |
Identification of retinoid-modulated proteins in squamous carcinoma cells using high-throughput immunoblotting.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Fenretinide; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Retinoids; Tretinoin | 2004 |
Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Fenretinide; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Receptors, Retinoic Acid; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Tretinoin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2006 |